Monoubiquitylation in the Fanconi anemia DNA damage response pathway
- PMID: 19264559
- DOI: 10.1016/j.dnarep.2009.01.019
Monoubiquitylation in the Fanconi anemia DNA damage response pathway
Abstract
The hereditary genetic disorder Fanconi anemia (FA) belongs to the heterogeneous group of diseases associated with defective DNA damage repair. Recently, several reviews have discussed the FA pathway and its molecular players in the context of genome maintenance and tumor suppression mechanisms [H. Joenje, K.J. Patel, The emerging genetic and molecular basis of Fanconi anaemia, Nat. Rev. Genet. 2 (2001) 446-457; W. Wang, Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins, Nat. Rev. Genet. 8 (2007) 735-748; L.J. Niedernhofer, A.S. Lalai, J.H. Hoeijmakers, Fanconi anemia (cross)linked to DNA repair, Cell 123 (2005) 1191-1198; K.J. Patel, Fanconi anemia and breast cancer susceptibility, Nat. Genet. 39 (2007) 142-143]. This review assesses the influence of post-translational modification by ubiquitin. We review and extract the key features of the enzymatic cascade required for the monoubiquitylation of the FANCD2/FANCI complex and attempt to include recent findings into a coherent mechanism. As this part of the FA pathway is still far from fully understood, we raise several points that must be addressed in future studies.
Similar articles
-
Fanconi anemia and DNA replication repair.DNA Repair (Amst). 2007 Jul 1;6(7):885-90. doi: 10.1016/j.dnarep.2007.02.002. Epub 2007 May 3. DNA Repair (Amst). 2007. PMID: 17481966 Review.
-
Mechanism of Ubiquitination and Deubiquitination in the Fanconi Anemia Pathway.Mol Cell. 2017 Jan 19;65(2):247-259. doi: 10.1016/j.molcel.2016.11.005. Epub 2016 Dec 13. Mol Cell. 2017. PMID: 27986371
-
Activation of the FA pathway mediated by phosphorylation and ubiquitination.Mutat Res. 2017 Oct;803-805:89-95. doi: 10.1016/j.mrfmmm.2017.05.003. Epub 2017 May 5. Mutat Res. 2017. PMID: 28552166 Review.
-
C. elegans: a model of Fanconi anemia and ICL repair.Mutat Res. 2009 Jul 31;668(1-2):103-16. doi: 10.1016/j.mrfmmm.2008.11.007. Epub 2008 Nov 19. Mutat Res. 2009. PMID: 19059419 Review.
-
The Fanconi anemia ID2 complex: dueling saxes at the crossroads.Cell Cycle. 2014;13(19):2999-3015. doi: 10.4161/15384101.2014.956475. Cell Cycle. 2014. PMID: 25486561 Free PMC article. Review.
Cited by
-
Physical interaction between SLX4 (FANCP) and XPF (FANCQ) proteins and biological consequences of interaction-defective missense mutations.DNA Repair (Amst). 2015 Nov;35:48-54. doi: 10.1016/j.dnarep.2015.09.022. Epub 2015 Sep 30. DNA Repair (Amst). 2015. PMID: 26453996 Free PMC article.
-
Gene silencing of FANCF potentiates the sensitivity to mitoxantrone through activation of JNK and p38 signal pathways in breast cancer cells.PLoS One. 2012;7(8):e44254. doi: 10.1371/journal.pone.0044254. Epub 2012 Aug 28. PLoS One. 2012. PMID: 22952942 Free PMC article.
-
Emerging Roles of Non-proteolytic Ubiquitination in Tumorigenesis.Front Cell Dev Biol. 2022 Jul 6;10:944460. doi: 10.3389/fcell.2022.944460. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35874839 Free PMC article. Review.
-
Rad18 E3 ubiquitin ligase activity mediates Fanconi anemia pathway activation and cell survival following DNA Topoisomerase 1 inhibition.Cell Cycle. 2011 May 15;10(10):1625-38. doi: 10.4161/cc.10.10.15617. Epub 2011 May 15. Cell Cycle. 2011. PMID: 21478670 Free PMC article.
-
RAD6B is a major mediator of triple negative breast cancer cisplatin resistance: Regulation of translesion synthesis/Fanconi anemia crosstalk and BRCA1 independence.Biochim Biophys Acta Mol Basis Dis. 2020 Jan 1;1866(1):165561. doi: 10.1016/j.bbadis.2019.165561. Epub 2019 Oct 19. Biochim Biophys Acta Mol Basis Dis. 2020. PMID: 31639439 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous